Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial-Reference-Cited by-同舟云学术

Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

Published:2018-10 Issue:10154 Volume:392 Page:1207-1216
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Opoku Nicholas O,Bakajika Didier K,Kanza Eric M,Howard Hayford,Mambandu Germain L,Nyathirombo Amos,Nigo Maurice M,Kasonia Kambale,Masembe Safari L,Mumbere Mupenzi,Kataliko Kambale,Larbelee Jemmah P,Kpawor Mawolo,Bolay Kpehe M,Bolay Fatorma,Asare Sampson,Attah Simon K,Olipoh George,Vaillant Michel,Halleux Christine M,Kuesel Annette C

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Helminthic diseases: onchocerciasis and loiasis;Remme,2017

2. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis;Basanez;Lancet Infect Dis,2008

3. Progress toward elimination of onchocerciasis in the Americas 1993–2012;MMWR Morb Mortal Wkly Rep,2013

4. Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus;Botto;Parasit Vectors,2016

5. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results;Tekle;Infect Dis Poverty,2016

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis;Trends in Parasitology;2024-09

2. Advancing Research and Development of Anti-infectives for Children: A Clinical Development Perspective;International Journal of Antimicrobial Agents;2024-08

3. An Updated Economic Assessment of Moxidectin Treatment Strategies for Onchocerciasis Elimination;Clinical Infectious Diseases;2024-04-25

4. Safety and Short-term Efficacy of a Single Dose of 2 mg Moxidectin in Loa loa–Infected Individuals: A Double-Blind, Randomized Ivermectin-Controlled Trial With Ascending Microfilarial Densities;Open Forum Infectious Diseases;2024-04-25

5. Parasitic Diseases;Rook's Textbook of Dermatology;2024-03-19